Named-Patient Program allows physicians and their patients to access drugs which have not yet received approval for marketing by concerned health authorities of the country. Governments worldwide have created provisions for granting access to drugs prior to approval for patients who have exhausted all alternative treatment options and do not match clinical trial entry criteria, Often grouped under the labels of compassionate use, expanded access criteria, data collection, promotion, and control of drug distribution.
We at Ikris Pharma Network believe in constant innovation to help patients connect to the world of pharmaceutical medicine suppliers and manufacturers, who offer genuine products at competitive price. Currently, we are catering to patients in all the major continents, across the globe.
Delivering medicine on time and at economical price, is what, that sets us apart from others. Our workforce comprises of skilled and efficient professionals who leave no stone unturned in order to ensure timely, legal & compliant deliver of medicines to needy patients anywhere in the world.
Geographical boundaries are no more constraint for needy patient in getting otherwise unavailable medicines